tech providers
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
cGMP manufacturing
facility in Panoli,
Gujarat, India, using
proprietary
purification technology
to achieve endotoxin
levels that are below
required thresholds to
help reduce the
potential for adverse
chemical reactions. For
example, J.T.Baker
HPLE galactose
of biopharmaceutical
streamline
contains significantly
product discovery and production and
lower levels of trace
development, and it
eliminate
metals when compared
appears that
variability in
to standard galactose
engineering and
biopharma and
available through
reverse-engineering of
pharma
multicompendial
carbohydrate
sources. This is crucial
attachment can prove a manufacturing?
powerful tool in the
We recently developed for biopharmaceutical
manufacturers with
field of biosimilars and and introduced
established cell culture
protein-therapeutic
J.T.Baker High Purity
engineering, as well as Low Endotoxin (HPLE) processes that rely on
highly controlled levels
helping streamline
sugars to help reduce
of metal in order to
Food and Drug
variability and
Administration (FDA) streamline production reach desired yield for
a target molecule.
approval processes.
in biopharmaceutical
manufacturing. These
Another way we are
How is Avantor
products are
helping our
helping to
manufactured at our
50
BioVoiceNews | Dec 2017 - Jan 2018